PAPER Llorens F, Villar-Piqué A, Hermann P, Schmitz M, Calero O, Stehmann C, Sarros S, Moda F, Ferrer I, Poleggi A, Pocchiari M, Catania M, Klotz S, O'Regan C, Brett F, Heffernan J, Ladogana A, Collins SJ, Calero M, Kovacs GG, Zerr I
SEARCH RESULTS
307 RESULTS
PAPER Ortega JA, Daley EL, Kour S, Samani M, Tellez L, Smith HS, Hall EA, Esengul YT, Tsai YH, Gendron TF, Donnelly CJ, Siddique T, Savas JN, Pandey UB, Kiskinis E
Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity.
Neuron. 2020 Apr 8;106(1):90-107.e13. Epub 2020 Feb 13 PubMed: 32059759PAPER Du Y, Fu M, Huang Z, Tian X, Li J, Pang Y, Song W, Tian Wang Y, Dong Z
TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease.
Aging Cell. 2020 Mar;19(3):e13113. Epub 2020 Feb 14 PubMed: 32061032PAPER Kim BY, Lim HS, Kim YJ, Sohn E, Kim YH, Koo I, Jeong SJ
Similarity of therapeutic networks induced by a multi-component herbal remedy, Ukgansan, in neurovascular unit cells.
Sci Rep. 2020 Feb 14;10(1):2658. PubMed: 32060346PAPER Dalboni da Rocha JL, Bramati I, Coutinho G, Tovar Moll F, Sitaram R
Fractional Anisotropy changes in Parahippocampal Cingulum due to Alzheimer's Disease.
Sci Rep. 2020 Feb 14;10(1):2660. PubMed: 32060334PAPER Shallie OF, Dalle E, Mabandla MV
Memory decline correlates with increased plasma cytokines in amyloid-beta (1-42) rat model of Alzheimer's disease.
Neurobiol Learn Mem. 2020 Mar;169:107187. Epub 2020 Feb 12 PubMed: 32059978PAPER Lax N, Fainstein N, Nishri Y, Ben-Zvi A, Ben-Hur T
Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer's disease mice.
J Neuroinflammation. 2020 Feb 14;17(1):55. PubMed: 32059733PAPER Maciejczyk M, Zalewska A, Gerreth AK
Salivary Redox Biomarkers in Selected Neurodegenerative Diseases.
J Clin Med. 2020 Feb 12;9(2) PubMed: 32059422PAPER Navarro-Martínez R, Cauli O
Therapeutic Plasmapheresis with Albumin Replacement in Alzheimer's Disease and Chronic Progressive Multiple Sclerosis: A Review.
Pharmaceuticals (Basel). 2020 Feb 12;13(2) PubMed: 32059404PAPER Owasil R, O'Neill R, Keable A, Nimmo J, MacGregor Sharp M, Kelly L, Saito S, Simpson JE, Weller RO, Smith C, Attems J, Wharton SB, Yuen HM, Carare RO
The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy.
Int J Mol Sci. 2020 Feb 12;21(4) PubMed: 32059400PAPER Wong LC, Wong MY, Tan CS, Vrooman H, Venketasubramanian N, Cheng CY, Chen C, Hilal S
Interethnic differences in neuroimaging markers and cognition in Asians, a population-based study.
Sci Rep. 2020 Feb 14;10(1):2655. PubMed: 32060376Erica Peacock
University of British ColumbiaVancouver, Canada
David Sanders on CryoEM of CBD Tau Suggests Another Unique Protofibril
COMMENT These two papers from Fitzpatrick/Petrucelli and Scheres/Goedert represent a major advance toward a holistic structural understanding of the tau fibril conformers that drive distinct neurodegenerative tauopathies (i.e. "strains", which link spec
PAPER Murakami K, Yoshimura M, Nakagawa S, Kume T, Kondo T, Inoue H, Irie K
Evaluation of Toxic Amyloid 42 Oligomers in Rat Primary Cerebral Cortex Cells and Human iPS-derived Neurons Treated with 10-Me-Aplog-1, a New PKC Activator.
Int J Mol Sci. 2020 Feb 11;21(4) PubMed: 32053979PAPER Ye R, Touroutoglou A, Brickhouse M, Katz S, Growdon JH, Johnson KA, Dickerson BC, Gomperts SN
Topography of cortical thinning in the Lewy body diseases.
Neuroimage Clin. 2020 Jan 31;26:102196. PubMed: 32059167Current Filters
- Date Range : Feb 2020 to Feb 2020 x